Current Studies

Here is a list of some of our current studies. For additional studies, please visit RecruitMe.

  • Principal Investigator:

    Bret R. Rutherford, MD
    In this research study, you will receive a medication called carbidopa/levodopa (Sinemet). This medication is approved by the Food and Drug Administration for the treatment of Parkinson's Disease. We are using carbidopa/levodopa off-label in this study to see whether it is capable of improving depressive symptoms as well as mental and physical slowing that occur as people age.
  • Principal Investigator:

    Helen Blair Simpson, MD, PhD
    The goal of the project is to identify differences in learning and memory in obsessive-compulsive disorder (OCD) and anxiety by looking at computer task performance of (1) individuals with OCD, (2) individuals with anxiety, and (3) individuals without OCD/anxiety. Eligible participants will be asked questions about their medical and psychiatric history and perform tasks on a computer. The study can be completed online in one sitting. Participants will be compensated for their time and effort.
  • Principal Investigator:

    Jermaine Jones, PhD
    This proposal will utilize a dual approach, studying methamphetamine users who are HIV-positive (Study A), and those who are HIV negative (Study B). Study A (N=125) is a quantitative investigation. Various self-report and clinician-administered inventories will be given to investigate the frequency and severity of co-morbidities related to methamphetamine abuse that may impact NNRTI-based HIV-1 treatment. Among methamphetamine users who are HIV negative, maintaining this status is of immense public health importance. Pre-exposure prophylaxis (PrEP), using antiretroviral drugs, has proven...
  • Principal Investigator:

    Elias Dakwar, MD
    This 12-week free and confidential outpatient study is recruiting healthy adults who are currently seeking treatment for alcohol use. Participants will engage in twice-weekly clinic visits during which they will meet with a physician and complete measures with research assistants. Participants will also receive innovative, investigative medications twice throughout this trial (Weeks 2 and 5) to help facilitate their engagement in treatment. Upon completion of the study, participants will be referred to appropriate community providers to ensure that they have the necessary means to continue...
  • Principal Investigator:

    Elias Dakwar, MD
    This 12-week free and confidential outpatient study is recruiting healthy adults who are currently seeking treatment for cocaine use. Participants will engage in twice-weekly clinic visits during which they will have mindfulness-based therapy sessions, meet with a physician, and complete measures with research assistants. Participants will also receive innovative investigational medications twice throughout this trial (Weeks 1 and 5) to help facilitate their engagement in treatment. Upon completion of the study, participants will be referred to appropriate community providers to ensure that...
  • Principal Investigator:

    Elias Dakwar, MD
    This free and confidential study is recruiting healthy adults who are currently seeking treatment for opioid use (heroin, painkillers). Participants will be admitted into our inpatient unit for the first 3 to 5 days of the study. In addition to traditional medications used during detoxification, you will also receive innovative, investigative medications that may help with the transition onto Vivitrol (extended-release nalrexone). After discharge from the inpatient unit, participants will engage in twice-weekly outpatient visits for 12 weeks. These visits involve therapy sessions, meeting...
  • Principal Investigator:

    Brian A Fallon, MD
    Do you know anyone struggling with anxiety or worry related to any aspect of our current COVID-19 pandemic? This research study is an online low-intensity treatment study which aims to reduce anxiety and enhance resilience in this troubled time. All participants will receive brief anxiety reduction training using cognitive-behavioral strategies. In addition, two-thirds will be asked to engage in a daily mind-body practice (mindfulness meditation or Kundalini Yoga). Meditation and yoga may also help to reduce pain and improve energy and cognition a study for these common Lyme-related symptoms...
  • Principal Investigator:

    Jonathan E. Posner, MD
    Children with Attention-Deficit/Hyperactivity Disorder (ADHD) are typically treated with two types of medications: stimulants and non-stimulants. These medications work in different ways to treat ADHD symptoms, but we do not fully understand the brain mechanisms underlying the medications' effects. This study will use MRI scanning to look at changes in the brain associated with medication treatment of ADHD in children. In this study, we will be comparing two FDA-approved medication treatments for ADHD in children: (1) A stimulant called Vyvanse (lisdexamfetamine); (2) A non-stimulant...
  • Principal Investigator:

    Jonathan E. Posner, MD
    Children with Attention-Deficit/Hyperactivity Disorder (ADHD) are typically treated with two types of medications: stimulants and non-stimulants. These medications work in different ways to treat ADHD symptoms, but we do not fully understand the brain mechanisms underlying the medications' effects. This study will use MRI scanning to look at changes in the brain associated with medication treatment of ADHD in children. In this study, we will be comparing two FDA-approved medication treatments for ADHD in children: (1) A stimulant called Vyvanse (lisdexamfetamine); (2) A non-stimulant...
  • Principal Investigator:

    Steven P. Roose, MD
    The purpose of this research study is to find out which antidepressants work best in individuals over the age of 60 years. We invite you to participate in this research study because you are 60+ years old have depression and your depression has not gotten better even after taking two or more medications.

Pages